Uzņēmumu paziņojumi · 14.11.2026.1 min read

Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List

Vietējais automātiskais tulkojums · Avota oriģinālvaloda

Illustration generated by Business News; it is not a source photograph.

Summary

PALO ALTO, Calif. and SUZHOU, China, Nov. 14, 2026 — Innovent Biologics, Inc.

Avota oriģinālvaloda: PR Newswire — Global News ReleasesAtvērt sākotnējo paziņojumu →